159 related articles for article (PubMed ID: 1240)
1. Problems with practolol.
Wall-Manning HJ
Drugs; 1975; 10(5-6):336-41. PubMed ID: 1240
[No Abstract] [Full Text] [Related]
2. Adverse reaction to the beta-adrenergic blocking drugs.
Brigden WD; Almeyda J
Br J Dermatol; 1976 Sep; 95(3):335-8. PubMed ID: 974021
[No Abstract] [Full Text] [Related]
3. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker.
Frishman W; Silverman R; Strom J; Elkayam U; Sonnenblick E
Am Heart J; 1979 Aug; 98(2):256-62. PubMed ID: 36744
[No Abstract] [Full Text] [Related]
4. Beta-adrenoceptor blocking drugs: adverse reactions and drug interactions.
Kendall MJ; Beeley L
Pharmacol Ther; 1983; 21(3):351-69. PubMed ID: 6138787
[TBL] [Abstract][Full Text] [Related]
5. Eye and skin reactions precede practolol peritonitis.
Idänpään-Heikkilä JE; Hästbacka J; Järvinen HJ
Lancet; 1977 Dec 24-31; 2(8052-8053):1354. PubMed ID: 74720
[No Abstract] [Full Text] [Related]
6. A ranked presentation of the MHRA/CSM (Medicines & Health Care Regulatory Agency/Committee on Safety of Medicines) Drug Analysis Print (DAP) data on practolol.
Mann RD
Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):705-10. PubMed ID: 16088980
[TBL] [Abstract][Full Text] [Related]
7. [Fibrinous peritonitis and ocular reactions: a complication of practolol therapy (author's transl)].
Kestens PJ; Muschart JM; Koerperich G; Aubry E
Acta Gastroenterol Belg; 1977; 40(3-4):175-87. PubMed ID: 899618
[No Abstract] [Full Text] [Related]
8. [Letter: Skin reactions due to practolol].
Marghescu S
Hautarzt; 1975 Dec; 26(12):663. PubMed ID: 1213887
[No Abstract] [Full Text] [Related]
9. Practolol and the safety of other beta blockers.
Sutherland DC; Wilson JD
N Z Med J; 1976 Oct; 84(573):282-5. PubMed ID: 12491
[TBL] [Abstract][Full Text] [Related]
10. Adverse reactions to practolol: some observations on the possible relevence to immune mechanisms.
Dick HM; Wright P; Chapman CM; Zacharias FJ; Nicholls JT
Allergy; 1978 Apr; 33(2):71-5. PubMed ID: 80139
[TBL] [Abstract][Full Text] [Related]
11. Possible role of antibody specific for a practolol metabolite in the pathogenesis of oculomucocutaneous syndrome.
Amos HE; Lake BG; Artis J
Br Med J; 1978 Feb; 1(6110):402-4. PubMed ID: 146533
[TBL] [Abstract][Full Text] [Related]
12. [Betablockers and skin (author's transl)].
Bonnetblanc JM; Roux J
Ann Dermatol Venereol; 1979 Nov; 106(11):927-30. PubMed ID: 44166
[TBL] [Abstract][Full Text] [Related]
13. [Oculocutaneous reactions following treatment with betablockers].
Erikssen J
Tidsskr Nor Laegeforen; 1976 Aug; 96(24):1288-9. PubMed ID: 9706
[No Abstract] [Full Text] [Related]
14. Editorial: Beta-blockers and the eye.
Br J Ophthalmol; 1976 May; 60(5):311. PubMed ID: 8075
[No Abstract] [Full Text] [Related]
15. Letter: Ocular reactions to beta-blockers.
Lyall JR
Br Med J; 1975 Jun; 2(5973):747. PubMed ID: 237597
[No Abstract] [Full Text] [Related]
16. Letter: Report on adverse reactions associated with practolol.
Proctor CR
Med J Aust; 1974 Nov; 2(20):758. PubMed ID: 4280498
[No Abstract] [Full Text] [Related]
17. An instructive example of a long-latency adverse drug reaction--sclerosing peritonitis due to practolol.
Mann RD
Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1211-6. PubMed ID: 17853493
[TBL] [Abstract][Full Text] [Related]
18. [Drug eruptions caused by beta-blockers].
Bonnetblanc JM
Ann Med Interne (Paris); 1984; 135(8):639-41. PubMed ID: 6152136
[TBL] [Abstract][Full Text] [Related]
19. Letter: Cross-sensitivity between practolol and other beta-blockers?
Zacharias FJ
Br Med J; 1976 May; 1(6019):1213. PubMed ID: 5172
[No Abstract] [Full Text] [Related]
20. [Adrenergic beta receptor blockaders].
Naess K
Tidsskr Nor Laegeforen; 1975 Feb; 95(6):380-3. PubMed ID: 235805
[No Abstract] [Full Text] [Related]
[Next] [New Search]
